Literature DB >> 23387876

Iron deficiency anemia in infants: does it really affect the myocardial functions?

Bulent Alioglu1, Ibrahim Ilker Cetin, Zeynep Sengul Emeksiz, Nermin Dindar, Esra Tapci, Yildiz Dallar.   

Abstract

The aim was to assess the myocardial functions in infants with iron deficiency anemia (IDA). The findings of 22 infants with IDA and 16 healthy infants were compared. Complete blood count in all infants, serum iron level, total iron binding capacity (TIBC), and serum ferritin level in patients were evaluated. Echocardiography with tissue Doppler imaging (TDI) was performed in all infants. The mean hemoglobin was 8.5 versus 11 g/dL, hematocrit was 26.7 versus 33.1% and the mean corpuscular volume (MCV) was 59.8 versus 72.2 fL in patients and controls, respectively. The median serum iron level was 14.5 μg/dL, TIBC was 444 μg/dL, and serum ferritin level was 4.9 ng/mL in patients. There were significant differences between patients and controls for the myocardial performance indexes of the left ventricle (LV) (0.57 vs. 0.45, P < .05), interventricular septum (IVS) (0.56 vs. 0.48, P < .05), and the right ventricle (RV) (0.56 vs. 0.41, P < .05). The similar significances were also present for the ejection times (ET) of the LV (173.1 vs. 212.1 ms, P < .05), IVS (173.7 vs. 195.6 ms, P < .05), and RV (169.9 vs. 213.3 ms, P < .05). In spite of negatively significant correlations between hemoglobin, hematocrit, MCV and MPI, the correlations between these parameters and ET were positively significant. However, there were no correlations between serum iron level, TIBC, serum ferritin level, and the TDI parameters of patients. According to these findings, we could say that, the IDA affects the myocardial functions in a negative manner.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23387876     DOI: 10.3109/08880018.2012.763077

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  2 in total

1.  Short-Term Changes in Left and Right Ventricular Cardiac Magnetic Resonance Feature Tracking Strain Following Ferric Carboxymaltose in Patients With Heart Failure: A Substudy of the Myocardial-IRON Trial.

Authors:  Irene Del Canto; Enrique Santas; Ingrid Cardells; Gema Miñana; Patricia Palau; Pau Llàcer; Lorenzo Fácila; Raquel López-Vilella; Luis Almenar; Vicent Bodí; Maria P López-Lereu; Jose V Monmeneu; Juan Sanchis; David Moratal; Alicia M Maceira; Rafael de la Espriella; Francisco J Chorro; Antoni Bayés-Genís; Julio Núñez
Journal:  J Am Heart Assoc       Date:  2022-03-18       Impact factor: 6.106

2.  Short-term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial-IRON trial.

Authors:  Enrique Santas; Gema Miñana; Ingrid Cardells; Patricia Palau; Pau Llàcer; Lorenzo Fácila; Luis Almenar; Maria P López-Lereu; Jose V Monmeneu; Juan Sanchis; Alicia M Maceira; Antoni Bayés-Genís; Julio Núñez
Journal:  ESC Heart Fail       Date:  2020-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.